Evidence map›Paper›PMID 38633011›Full record

ArticleInfectious diseases & clinical microbiology2023

The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19.

Yeşim Yıldız, Hasan Selçuk Özger, Ali Acar, Ayşegül Seremet-Keskin, Umut Devrim Binay, Gülten Ünlü, Halim Bayram, Ali Asan, Mustafa Özgür Akça, Dilek Karamanlioğlu and 20 more

Abstract read
In one paragraph

Article in Infectious diseases & clinical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Yeşim YıldızDepartment of Infectious Disease and Clinical Microbiology, Gazi University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0003-3006-4112
Hasan Selçuk ÖzgerDepartment of Infectious Disease and Clinical Microbiology, Gazi University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0003-3894-0092
Ali AcarDepartment of Infectious Disease and Clinical Microbiology, Atılım University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0003-2008-5112
Ayşegül Seremet-KeskinDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.ORCID https://orcid.org/0000-0002-9224-4699
Umut Devrim BinayDepartment of Infectious Diseases and Clinical Microbiology, Erzincan Binali Yildirim University School of Medicine, Erzincan, Turkey.ORCID https://orcid.org/0000-0003-3841-9109
Gülten ÜnlüDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.ORCID https://orcid.org/0000-0002-1260-5109
Halim BayramDepartment of Infectious Diseases and Clinical Microbiology, Gaziantep Dr Ersin Arslan Tranining and Research Hospital, Gaziantep, Turkey.ORCID https://orcid.org/0000-0002-0023-0645
Ali AsanDepartment of Infectious Diseases and Clinical Microbiology, University of Health Science, Bursa Training and Research Hospital, Bursa, Turkey.ORCID https://orcid.org/0000-0002-8856-7356
Mustafa Özgür AkçaDepartment of Infectious Diseases and Clinical Microbiology, University of Health Science, Bursa Training and Research Hospital, Bursa, Turkey.ORCID https://orcid.org/0000-0001-7988-0095
Dilek KaramanlioğluDepartment of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara, Turkey.ORCID https://orcid.org/0000-0002-8160-8231
Osman İnanDepartment of Internal Medicine, Ankara City Hospital, Ankara, Turkey.ORCID https://orcid.org/0000-0002-8717-3013
Şafak KayaDepartment of Infectious Diseases and Clinical Microbiology, University of Health Sciences Diyarbakır Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkey.ORCID https://orcid.org/0000-0001-9912-7340
Çiğdem YıldırımDepartment of Infectious Diseases and Clinical Microbiology, Pursaklar State Hospital, Ankara, Turkey.ORCID https://orcid.org/0000-0002-9032-4046
Yusuf ArslanDepartment of Infectious Diseases and Clinical Microbiology, Batman Training and Research Hospital, Batman, Turkey.ORCID https://orcid.org/0000-0002-1479-6009
Süheyla KömürDepartment of Infectious Disease and Clinical Microbiology, Çukurova University School of Medicine, Adana, Turkey.ORCID https://orcid.org/0000-0003-2414-559X
Yasemin SaygıdeğerDepartment of Pulmonary, Çukurova University School of Medicine, Adana, Turkey.ORCID https://orcid.org/0000-0003-3293-373X
Fatma Özlem KandemirDepartment of Infectious Disease and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey.ORCID https://orcid.org/0000-0002-2602-5826
Simge YaşarDepartment of Infectious Disease and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey.ORCID https://orcid.org/0000-0002-6094-050X
İrem Akdemir-KalkanDepartment of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0001-5136-9148
Zeynep Tekin-TaşDepartment of Infectious Diseases and Clinical Microbiology, Sincan Dr. Nafiz Körez State Hospital, Ankara, Turkey.ORCID https://orcid.org/0000-0001-7232-8863
Ayşe SakızDepartment of Infectious Diseases and Clinical Microbiology, Mardin Training and Research Hospital, Mardin, Turkey.ORCID https://orcid.org/0000-0003-2230-5676
Yaşar BayındırDepartment of Infectious Diseases and Clinical Microbiology, İnönü University School of Medicine, Malatya, Turkey.ORCID https://orcid.org/0000-0003-3930-774X
Ayşe Belin ÖzerDepartment of Anesthesiology and Reanimation, İnönü University School of Medicine, Malatya, Turkey.ORCID https://orcid.org/0000-0002-0113-6466
Ayşe Özlem MeteDepartment of Infectious Diseases and Clinical Microbiology, Gaziantep University School of Medicine, Gaziantep, Turkey.ORCID https://orcid.org/0000-0003-0994-4465
Çiğdem ErolDepartment of Infectious Diseases and Clinical Microbiology, Başkent University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0002-2535-2534
Çiğdem MermutluoğluDepartment of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey.ORCID https://orcid.org/0000-0003-1836-6281
Ali Kemal KadiroğluDepartment of Nephrology, Dicle University School of Medicine, Diyarbakır, Turkey.ORCID https://orcid.org/0000-0002-7768-2455
Alpay AzapDepartment of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0001-5035-055X
Esin ŞenolDepartment of Infectious Disease and Clinical Microbiology, Gazi University School of Medicine, Ankara, Turkey.ORCID https://orcid.org/0000-0003-1535-2757
Adult Immunization Study Group of the Turkish Society of Clinical Microbiology and Infectious Diseases

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We aimed to investigate the vaccination status and the risk factors for the intensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpatients, divided into two groups as 'fully' and 'partially' vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mellitus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the predominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension ( Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vaccinated were associated with the need for ICU support. Therefore, all countries should continuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection.

Indexed as

COVID-19 vaccineintensive care unitrisk factorSARS-CoV-2 infectionvaccine breakthrough infectionsvariant of concerns

Identifiers

PMID38633011
PMCPMC10986718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.